Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2026-02-26 @ 7:49 PM
Study NCT ID:
NCT03706703
Status:
UNKNOWN
Last Update Posted:
2018-10-17
First Post:
2018-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
Sponsor:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ENDOSTAR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None